logo
Sign in

BRAXF Stock Price, Chart, Stats & News

Braxia Scientific Corp.
Save

Braxia Scientific Corp. (BRAXF) does not currently pay a dividend.

28,328
Market cap
Current P/E
Forward P/E

BRAXF chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

Braxia Scientific Corp. functions as a medical research entity that also runs clinics, offering ketamine therapies to individuals suffering from depression and linked conditions. Beyond its clinical services, the company is actively engaged in discovering and bringing to market novel pharmaceutical compounds and innovative delivery methods. Leveraging its intellectual property development platform, Braxia Scientific innovates by developing derivatives of ketamine and psilocybin, in addition to other psychedelic substances.

Similar securities

Based on sector and market capitalization

Report issue